Magsoothium Cbd Body Lavender

Description

Magsoothium CBD is a homeopathic pain reliever formulated as a lavender calming cream. This product is designed to assist in the relief of minor aches and pains. It is presented in a body cream dosage form, with a net content of 4 oz (112 ml). The formulation combines the soothing properties of lavender with the therapeutic benefits of CBD to provide a calming effect on the skin.

Uses and Indications

This drug is indicated for the relief of minor aches and pains.

There are no teratogenic effects associated with this drug, nor are there any nonteratogenic effects noted.

Dosage and Administration

For adults and children aged 2 years and older, the medication should be applied directly to the affected area. There is no requirement to rub, massage, or bandage the area after application. The application may be repeated as necessary; however, it is important not to exceed four applications within a 24-hour period.

For children under 2 years of age, it is advised to consult a physician prior to use.

Contraindications

Use is contraindicated in children due to the risk of accidental ingestion. In the event of accidental ingestion, it is imperative to seek medical assistance or contact a Poison Control Center immediately.

Warnings and Precautions

This product is intended for external use only. Healthcare professionals should advise patients to use the product strictly as directed. It is imperative that the treated area is not bandaged or covered, as this may interfere with the product's efficacy and safety. Additionally, patients should be cautioned against applying ice or heating pads in conjunction with this product, as such practices may lead to adverse effects.

The use of this product with any medical device or other devices is contraindicated. Furthermore, it should not be combined with any other topical treatments, as this may increase the risk of skin irritation or other complications. Care should be taken to avoid contact with the eyes or mucous membranes, and the product must not be applied to wounds or damaged skin to prevent potential harm.

For patients who are pregnant or breastfeeding, it is essential to consult a healthcare professional prior to use to ensure safety for both the mother and child. In the event of accidental ingestion, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay.

Side Effects

Patients using this product should be aware of several important warnings and precautions. This product is intended for external use only. When applying, patients should not bandage or cover the treated area, nor should they apply ice or a heating pad in conjunction with the product. It is also advised that patients refrain from using this product with any medical device or other topical treatments, as such combinations may lead to adverse effects.

Contact with the eyes or mucous membranes should be avoided, and the product must not be applied to wounds or damaged skin. Additionally, pregnant or breastfeeding patients are encouraged to consult a health professional prior to use to ensure safety for both themselves and their child.

Drug Interactions

The use of this medication is contraindicated with any medical device or other device, as well as with any other topical treatment. Co-administration may lead to adverse effects or diminished therapeutic efficacy.

There are no specific laboratory test interactions reported for this medication. Therefore, routine monitoring of laboratory tests is not required in relation to this drug.

Packaging & NDC

Below are the non-prescription pack sizes of Magsoothium Cbd Body Lavender (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be kept out of reach of children. In the event of accidental ingestion, medical help should be sought immediately, or contact a Poison Control Center.

For children aged 2 years and older, the recommended application is to apply the product directly onto the affected area without the need for rubbing, massaging, or bandaging. This can be repeated as necessary, but should not exceed four applications per day.

For children under 2 years of age, consultation with a physician is advised prior to use.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to assess the potential risks and benefits, as well as any available data regarding fetal outcomes and lactation. Healthcare providers can offer guidance tailored to individual circumstances, ensuring the safety of both the patient and the developing fetus or nursing infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and consider general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, ensuring adequate ventilation, and monitoring vital signs.

If available, specific antidotes or treatments should be administered according to established protocols. Additionally, healthcare professionals should consult local poison control centers or relevant clinical guidelines for further management recommendations tailored to the specific circumstances of the overdose.

Documentation of the incident, including the substance involved, estimated dose, time of exposure, and any symptoms observed, is crucial for ongoing management and treatment.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event of accidental ingestion, patients should be instructed to seek medical help or contact a Poison Control Center immediately. It is essential for patients to understand the importance of these precautions to ensure their safety and the safety of others.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light exposure to protect its quality. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

Patients should apply the medication directly onto the affected area without rubbing, massaging, or bandaging. The application may be repeated as necessary, but it should not exceed four times daily.

Clinicians should counsel patients to keep the product out of reach of children and to seek medical assistance or contact a Poison Control Center immediately in the event of accidental ingestion. Patients are advised to discontinue use and consult a doctor if their condition worsens, if symptoms persist for more than seven days, or if symptoms clear up and then recur. Additionally, pregnant or breastfeeding patients should consult a healthcare professional before use.

Drug Information (PDF)

This file contains official product information for Magsoothium Cbd Body Lavender, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)